Skip to main content
. 2014 Mar 12;14:176. doi: 10.1186/1471-2407-14-176

Table 3.

Relationship between expressions of survivin and its splice variants in tissues with clinical staging

Characteristic n Survivin Survivin-2B Survivin-ΔEx3
Stage II/III
7
+++ (62%)
+++ (0%)
+++ (50%)
 
 
++ (27%)
++ (25%)
++ (50%)
 
 
+ (11%)
+ (50%)
+ (0%)
 
 
0 (0%)
0 (25%)
0 (0%)
Stage IV
9
+++ (75%)
+++ (0%)
+++ (70%)
 
 
++ (19%)
++ (0%)
++ (25%)
 
 
+ (6%)
+ (19%)
+ (5%)
    0 (0%) 0 (81%) 0 (0%)
HHS Vulnerability Disclosure